Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6–8, 2014

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer Immunology, Immunotherapy Immunotherapy, 2015-07, Vol.64 (7), p.923-930
Hauptverfasser:	Kloke, Björn-Philipp, Mahr, Andrea, Jabulowsky, Robert A., Kutscher, Sarah, Rae, Richard, Britten, Cedrik M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antibodies, Monoclonal - therapeutic use Cancer Cancer Research Cancer Vaccines - therapeutic use Clinical trials CTLA-4 Antigen - immunology Cytotoxicity Dimensional analysis Germany Humans Immunology Immunotherapy Immunotherapy - methods Ipilimumab Ligands Lymphocytes Medicine Medicine & Public Health Meeting Report Melanoma Neoplasms - immunology Neoplasms - therapy Oncology Patients R&D Research & development Success T-Lymphocytes, Cytotoxic - immunology Tumor Microenvironment - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!